When the dose was increased from 1 mg to 2.4 mg per week, PwO without T2D lost on average 15% of their starting weight [18, 19]
Physical activity was assessed using Physical Activity Scale for Elderly (PASE)
Experts urge people currently using compounded GLP-1s to talk with their health care provider before making changes
Blog Posts Genitourinary Syndrome of Menopause (GSM) Learn about Genitourinary Syndrome of Menopause (GSM), including vaginal dryness, painful intercourse, recurrent UTIs, urinary symptoms, and evidence-based hormonal and non-hormonal treatments to improve comfort, intimacy, and quality of life
The guidance produced by the MHRA is sensible, since it highlights that women could accidentally get pregnant when taking GLP-1 drugs